Trial intelligence / Profile preview

Sildenafil in COPD-associated Pulmonary Hypertension

NCT00730067Phase 4Withdrawn

Sponsor
Aarhus University
Start
Jun 2012
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ASP-001 in pulmonary hypertension (PH), sponsored by Aarhus University. Planned start Jun 2012; status: withdrawn.

02

Drugs

ASP-001
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT00730067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00730067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call